Physician

Alfredo Enrique Torres Gonzalez, M.D

According to 2025 Medicare claims, Alfredo Gonzalez, M.D (NPI: 1285977546) practices hematology/oncology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 11776-0001. Gonzalez is affiliated with the ilumed, LLC (ACO ID: D0005) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Gonzalez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,602 traditional Medicare patients, billed 270,383 HCPCS/CPT codes, and received $3,452,553 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 2,370 prescription claims across 293 beneficiaries totaling $9,865,796 in drug costs, led by Revlimid (Lenalidomide). DME data shows 39 claims. Open Payments data shows 59 records totaling $65,898. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $173,612 to $3,452,553. Similarly, Part D prescription costs have risen steadily, from $7,323 to $9,865,796. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	176	10,559	$173,612
2020	924	153,011	$2,038,212
2021	814	132,440	$2,038,341
2022	1,014	117,302	$2,013,942
2023	2,179	242,233	$3,057,138
2024	2,602	270,383	$3,452,553

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	142	$7,323
2016	20	138	$77,687
2017	20	120	$114,708
2018	12	40	$89,171
2019	69	162	$235,999
2020	215	1,035	$1,709,060
2021	265	1,678	$3,537,574
2022	270	1,916	$6,218,964
2023	271	2,024	$8,630,807
2024	293	2,370	$9,865,796

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	102	$4,834
2022	N/R	51	$1,331
2023	N/R	60	$11,035
2024	N/R	39	$820

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	1,434	3,204	$10
36415	Insertion of needle into vein for collection of blood sample	1,494	3,783	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,604	3,889	$8
83735	Magnesium level	1,136	2,735	$7
84550	Uric acid level, blood	1,132	2,697	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	56	1,596	$1,024,986
Ibrance	Palbociclib	51	1,428	$827,649
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	66	1,848	$674,282
Givlaari	Givosiran Sodium	12	336	$640,339
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	72	1,966	$546,403

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	24	$575
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	15	$245

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	59	$65,898	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alfredo Enrique Torres Gonzalez, M.D?

Tedicare shows public-source Medicare data for Alfredo Enrique Torres Gonzalez, M.D (NPI 1285977546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alfredo Enrique Torres Gonzalez, M.D have ACO affiliation data?

Alfredo Enrique Torres Gonzalez, M.D is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Alfredo Enrique Torres Gonzalez, M.D?

Alfredo Enrique Torres Gonzalez, M.D is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Alfredo Enrique Torres Gonzalez, M.D have Open Payments data?

Alfredo Enrique Torres Gonzalez, M.D has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.